Literature DB >> 6310524

Construction and characterization of type II collagen complementary deoxyribonucleic acid clones.

L N Lukens, A M Frischauf, P J Pawlowski, G T Brierley, H Lehrach.   

Abstract

The mRNA for type II collagen was purified from embryonic chick sternum or from purified sternal chondrocytes with guanidine thiocyanate as the extractant. Double-stranded cDNAs to procollagen mRNAs from sternum were synthesized and dC-tailed. After annealing with PstI-cleaved, dG-tailed pBR322, this DNA was used to transform Escherichia coli X1776. Transformed colonies were screened by colony hybridization to type I and II collagen cDNAs. Clones that preferentially hybridized to type II cDNA were characterized further. Four such cDNA clones, pCgII-2, 3, 10 and 12, with inserts of 400, 320, 260 and 750 bp, have been identified as type II collagen cDNA clones by several criteria, including their preference for hybridizing with type II rather than type I collagen mRNAs in hybrid-selected translation experiments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310524      PMCID: PMC326333          DOI: 10.1093/nar/11.17.6021

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Study of differential collagen synthesis during development of the chick embryo by immunofluorescence. I. Preparation of collagen type I and type II specific antibodies and their application to early stages of the chick embryo.

Authors:  H von der Mark; K von der Mark; S Gay
Journal:  Dev Biol       Date:  1976-02       Impact factor: 3.582

2.  Primary activation of the vitellogenin gene in the rooster.

Authors:  R G Deeley; J I Gordon; A T Burns; K P Mullinix; M Binastein; R F Goldberg
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

3.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

4.  Purification and mapping of specific mRNAs by hybridization-selection and cell-free translation.

Authors:  R P Ricciardi; J S Miller; B E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

6.  Construction and characterization of pro alpha 1 collagen complementary deoxyribonucleic acid clones.

Authors:  H Lehrach; A M Frischauf; D Hanahan; J Wozney; F Fuller; H Boedtker
Journal:  Biochemistry       Date:  1979-07-10       Impact factor: 3.162

7.  Purification and properties of ovalbumin messenger RNA.

Authors:  M E Haines; N H Carey; R S Palmiter
Journal:  Eur J Biochem       Date:  1974-04-16

8.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

9.  Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage.

Authors:  E Vuorio; L Sandell; D Kravis; V C Sheffield; T Vuorio; A Dorfman; W B Upholt
Journal:  Nucleic Acids Res       Date:  1982-02-25       Impact factor: 16.971

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  10 in total

1.  Isolation and partial characterization of the entire human pro alpha 1(II) collagen gene.

Authors:  F O Sangiorgi; V Benson-Chanda; W J de Wet; M E Sobel; P Tsipouras; F Ramirez
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

2.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

3.  Primary structure of the telopeptide and a portion of the helical domain of chicken type II procollagen as determined by DNA sequence analysis.

Authors:  F Deák; W S Argraves; I Kiss; K J Sparks; P F Goetinck
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

Review 4.  Collagen genes and inherited connective tissue disease.

Authors:  K S Cheah
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

5.  Isolation of cDNA and genomic DNA clones encoding type II collagen.

Authors:  M F Young; G Vogeli; A M Nunez; M P Fernandez; M Sullivan; M E Sobel
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

6.  Tissue specificity of type I collagen gene expression is determined at both transcriptional and post-transcriptional levels.

Authors:  R J Focht; S L Adams
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

7.  Analysis of cDNA and genomic clones coding for the pro alpha 1 chain of calf type II collagen.

Authors:  F O Sangiorgi; V Benson-Chanda; W J de Wet; M E Sobel; F Ramirez
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

8.  Molecular cloning and carboxyl-propeptide analysis of human type III procollagen.

Authors:  H R Loidl; J M Brinker; M May; T Pihlajaniemi; S Morrow; J Rosenbloom; J C Myers
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

9.  Collagen expression in embryonic chicken chondrocytes treated with phorbol myristate acetate.

Authors:  M H Finer; L C Gerstenfeld; D Young; P Doty; H Boedtker
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

Review 10.  Identification of genes associated with tumor suppression in Syrian hamster embryo cells.

Authors:  R W Wiseman; J C Montgomery; J Hosoi; E W Hou; C J Cochran; P W Lamb; J C Barrett
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.